Katherine E. Gallagher

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Sophie Uyoga, Ifedayo Adetifa, Henry Karanja et al. · Science · 2020 · 339 citations · Full text

Status of HPV vaccine introduction and barriers to country uptake

Katherine E. Gallagher, D. Scott LaMontagne, Deborah Watson‐Jones · Vaccine · 2018 · 239 citations · Full text

Vaccine Hesitancy, Global Leadership, Cervical Cancer Prevention +17

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

Katherine E. Gallagher, Natasha Howard, Severin Kabakama et al. · PLoS ONE · 2017 · 118 citations · Full text

Progress in HPV vaccination in low‐ and lower‐middle‐income countries

D. Scott LaMontagne, Paul J. N. Bloem, Julia Brotherton et al. · International Journal of Gynecology & Obstetrics · 2017 · 108 citations · Full text

Vaccine Hesitancy, Covid-19, Preventive Medicine +17

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +9